A Fehrenbach
Nitroglycerin alters alveolar type II cell ultrastructure after ischemia and reperfusion
Fehrenbach A, Wittwer T, Meyer D, von Vietinghoff S, Viehöver M, Fehrenbach H, Richter J, Wahlers T. Nitroglycerin alters alveolar type II cell ultrastructure after ischemia and reperfusion. J Heart Lung Transplant 2001; 20:876-88.
01.08.2001Nitroglycerin alters alveolar type II cell ultrastructure after ischemia and reperfusion
01.08.2001J Heart Lung Transplant 2001; 20:876-88
Fehrenbach A, Wittwer T, Meyer Daniel, von Vietinghoff S, Viehöver M, Fehrenbach H, Richter J, Wahlers T
Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation
Wittwer T, Fehrenbach A, Meyer D, Brandes H, Albes J, Richter J, Wahlers T. Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation. J Heart Lung Transplant 2000; 19:976-83.
01.10.2000Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation
01.10.2000J Heart Lung Transplant 2000; 19:976-83
Wittwer T, Fehrenbach A, Meyer Daniel, Brandes H, Albes J, Richter J, Wahlers T
Beneficial effect of lung preservation is related to ultrastructural integrity of tubular myelin after experimental ischemia and reperfusion
Fehrenbach A, Richter J, Meyer D, Elki S, Schmiedl A, Wittwer T, Wahlers T, Warnecke T, Ochs M, Fehrenbach H. Beneficial effect of lung preservation is related to ultrastructural integrity of tubular myelin after experimental ischemia and reperfusion. Am J Respir Crit Care Med 2000; 161:2058-65.
01.06.2000Beneficial effect of lung preservation is related to ultrastructural integrity of tubular myelin after experimental ischemia and reperfusion
01.06.2000Am J Respir Crit Care Med 2000; 161:2058-65
Fehrenbach A, Richter J, Meyer Daniel, Elki S, Schmiedl A, Wittwer T, Wahlers T, Warnecke T, Ochs M, Fehrenbach H